This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 3Burkholderia cepacia complex
- 2Bacteriophage
- 1Aerosol phage therapy
- 1Bacteriophage receptors
- 1Bacteriophage therapy
- 1In vivo phage therapy
-
Spring 2013
In recent times, increased attention has been given to evaluating the efficacy of phage therapy, especially in scenarios where the bacterial infectious agent of interest is highly antibiotic resistant. In this regard, phage therapy is especially applicable to infections caused by the Burkholderia...
-
Spring 2013
Because of their ability to infect bacterial cells, bacteriophages or phages (viruses that infect and kill bacteria) show promise in treating diseases caused by multidrug resistant bacteria like the Burkholderia cepacia complex (Bcc). In order to carry out their lifecycle, phages must recognize,...
-
Fall 2017
In recent years, there has been a renewed interest in using bacteriophages as an alternate agent for the treatment of multi-drug resistant bacteria. One such highly drug-resistant group of bacteria is the Burkholderia cepacia complex (Bcc), which causes chronic infections in cystic fibrosis (CF)...